Value8 N.V (PREVA) fair value: what the stock is really worth
As of Oct 2, 2026: fair value of Value8 N.V €1.14, price €4.65, upside -75.6%, quality 61 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch Value8 N.V for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.
How to read this chart
60‑month range €2.75 – €5.18 · fair‑value band €0.8522 – €1.42 · the €4.65 price screens above the €1.14 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 24, 2026.
Follow Value8 in your weekly email
Every Wednesday you see whether Value8 is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Value8 N.V. is a private equity firm specializing in middle market, buyout, add-on and growth capital investments in small and medium-sized companies. The firm primarily invests in the food, healthcare, business and financial services, energy, safety and security, water and environment, leisure, luxury products and internet sectors.
Show more
Value8 N.V. is a private equity firm specializing in middle market, buyout, add-on and growth capital investments in small and medium-sized companies. The firm primarily invests in the food, healthcare, business and financial services, energy, safety and security, water and environment, leisure, luxury products and internet sectors. It typically invests in Western Europe, primarily in the Netherlands, Belgium and France. The firm considers investments in companies with an enterprise value between "10 million ($10.74 million) and "150 million ($208.87 million). The firm prefers to take a seat on the board of directors and seeks to exit the investment through a public listing. Value8 NV was founded in 2008 and is headquartered in Bussum, Netherlands.
Stock analysis
Value8 N.V (PREVA) currently trades at €4.65, while our model-based Fair Value estimate is €1.14, 75.6% below the price, so the stock looks overvalued today.
Show more
Valuation
How firm this estimate is: it rests on 16 models at a data quality of 95/100, which puts the evidence level at high.
Scenario range: €0.8522 (bear) to €1.42 (bull), the price of €4.65 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 61/100 (solid quality), in the Financial Services sector.
Mixed Growth: Spin-off in 2025: revenue and profit before it include the divested business. Growth is measured afresh from 2025.
Value8 N.V reported revenue of €2.9M in FY2025 versus €4.2M in FY2021, a compound −8.9%/yr. Reported net income was €16.9M in FY2025, compounding −2.2%/yr from FY2021.
Key figures
Market cap €11.8M · P/E ratio 2.5 · P/S ratio 14.9 · EPS (TTM) €1.87 · Dividend yield 4.5% · Net margin 83.1% · Return on equity 15.2% · Return on assets (EBIT) 8.0%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 47 out of 100 (low confidence).
What moves the price
The share trades about 4% below its 52-week high and 7% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Financial Services peers we cover trades at −15% fair-value upside, at −76%, PREVA screens richer than that median.
Fair Value models
Bear €0.8522Fair Value €1.14Bull €1.42
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2025 figures (about 9 months old). Earnings retained since then (€1.25 per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.55/100
Spin-off in 2025: revenue and profit before it include the divested business. Growth is measured afresh from 2025.
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+8.9%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−2.8%
Revenue growth 20 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−8.3%
’13
’14
’15
’16
’17
’18
’19
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years) (mathematically smoothed) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Smoothed = median of all growth paths between the years of the window (trend line on the logarithm of earnings per share): a single extreme year cannot distort the rate. The reported figure stays in the tooltip.
+10.4%
Earnings growth per share plus dividend.
Earnings per share, growth per year+5.9%
Dividend (yield on the price)4.5%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.14.3% vs 10.9%, picking up
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.1,167% → 629%
2025 sits 161% above its own trend. The rate follows the median trend of the last 5 years, not that single year.
Start year 2020 (pandemic)
⚠ Revenue per share shrinking 32.0%/yr over ~10Y (margins intact) ⓘStructural-decline marker: revenue PER SHARE has fallen over the last decade (robust median trend, not a single year). Backtested across 2005 to 2017, such businesses trailed the market by about 2.5 percentage points per year. Display only: it does not change the fair value or the quality score.
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Asset Management · 655 stocks
Beats the industry median on 11/12 measures
Overall it ranks above its industry peers.
Valuation
Quality Score64 · Above median
Fair Value upside+64.8% · Above median
Profitability
Return on equity (TTM)15.2% · Above median
Return on assets9.0% · Top 25%
Net margin (TTM)83.1% · Top 25%
Operating margin (TTM)90.1% · Top 25%
Growth and dividend
Revenue growth−11.6% · Bottom 25%
Dividend yield (TTM)4.5% · Above median
Valuation Multiplesvs Asset Management median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Value8 N.V Fair Value". https://www.fairvalue-calculator.com/stock/PREVA
Frequently asked questions
Is Value8 N.V (PREVA) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of €1.14 versus a price of €4.65, about −76% upside (overvalued).
What is the fair value of PREVA?
Our model-based fair value for Value8 N.V is €1.14 (as of Sep 24, 2026), built from audited fundamentals. The current price: €4.65.
What is the quality score of PREVA?
Value8 N.V has a Quality Score of 61/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Value8 N.V (PREVA)?
Our model-based price target is the fair value of €1.14 (as of Sep 24, 2026) from 2 valuation models. Cautious scenario €0.8522, optimistic scenario €1.42. It is a calculation from audited fundamentals, not an analyst target.
What is the Value8 N.V stock forecast for 2026?
Our models put fair value at €1.14, about −76% upside versus a price of €4.65 (overvalued). Cautious scenario €0.8522, optimistic scenario €1.42. The calculation is refreshed regularly with new filings.
Does Value8 N.V pay a dividend?
Value8 N.V currently shows a dividend yield of about 4.52% relative to its recent price (as of Sep 24, 2026).
What is the intrinsic value of Value8 N.V (PREVA)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Value8 N.V it is €1.14 per share (as of Sep 24, 2026), against a price of €4.65. It is the blended result of 2 valuation models (cash flow, earnings, asset, dividend).
Is Value8 N.V stock overvalued or undervalued in 2026?
As of Sep 24, 2026, PREVA trades above its calculated fair value: price €4.65, fair value €1.14, a gap of about −76% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of PREVA?
No. The price is what the market pays today (€4.65); the fair value is what the company's own numbers justify (€1.14). For Value8 N.V the two are €3.51 per share apart. That gap is exactly why we show both numbers side by side.
How much is Value8 N.V worth?
The market values Value8 N.V at about €11.8M (market capitalisation, as of Sep 24, 2026). Per share that is €4.65; our models calculate a fair value of €1.14 per share.
What do the bullish and bearish scenarios say about PREVA?
Our models span a range for Value8 N.V: cautious scenario €0.8522, base €1.14, optimistic €1.42 per share (as of Sep 24, 2026, price €4.65). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of PREVA?
Value8 N.V trades at a price-to-earnings ratio of 2.5 (as of Sep 24, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of €1.14 is built from several models across several years. Other multiples: P/B 0.1, P/S 0.7, EV/EBITDA 0.7.
How solid is the balance sheet of Value8 N.V (PREVA)?
Balance-sheet figures for Value8 N.V (as of Sep 24, 2026): return on equity 15.2%. They feed the Quality Score of 61/100, which measures business quality independently of the share price.
How far is PREVA from its 52-week high?
Value8 N.V trades at €4.65, about 4% below its 52-week high of €4.82 and 7% above the low of €4.36 (as of Oct 2, 2026). Distance from the high says nothing about value: that is what the fair value of €1.14 is for.
Which stocks are comparable to Value8 N.V?
From the same area (Financial Services) we also value Blackstone Inc, KKR & Co, Brookfield Corporation, Apollo Global Management, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Value8 N.V stock attractive at the current price?
The data as of Sep 24, 2026: price €4.65, calculated fair value €1.14 (−76%), Quality Score 61/100, from 2 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of PREVA calculated?
We run Value8 N.V through 2 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of €1.14, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5 % above its aggregate fair value. Value8 N.V itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Value8 N.V (PREVA)?
The closing price on Oct 2, 2026 was €4.65. Our model-based fair value is €1.14, about −76% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Value8 N.V right now?
The price sits above even our optimistic bull case (€1.42). The favourable scenario is already priced in. Solid but not exceptional quality (61/100) and above fair value, neither a clear bargain nor a standout compounder. For a financial, book-value and earnings-based methods matter more than a cash-flow DCF, which fits banks and insurers poorly.
Key figures of Value8 N.V
How large is the market capitalisation of Value8 N.V (PREVA)?
The market capitalisation of Value8 N.V is €11.8M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Value8 N.V (PREVA)?
The price-to-sales ratio of Value8 N.V is 14.9 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Value8 N.V (PREVA)?
Earnings per share at Value8 N.V are €1.87 (price ÷ EPS = P/E 2.5). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Value8 N.V (PREVA)?
The dividend yield of Value8 N.V is 4.5% (payout 11.2%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Value8 N.V (PREVA)?
The net margin of Value8 N.V is 83.1% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Value8 N.V (PREVA)?
The return on equity (ROE) of Value8 N.V is 15.2% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Value8 N.V (PREVA)?
On an EBIT basis the return on assets of Value8 N.V is 8.0% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Value8 N.V (PREVA)?
The operating margin of Value8 N.V is 90.1% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Value8 N.V (PREVA)?
Revenue at Value8 N.V is growing −11.6% versus a year earlier (3y avg −11.6%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Value8 N.V (PREVA)?
Earnings per share at Value8 N.V are growing −31.5% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Value8 N.V (PREVA) generate?
The free cash flow of Value8 N.V is −€904K (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Value8 N.V (PREVA) carry?
The net debt of Value8 N.V is €17.5M (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Value8 N.V in the live analysis
One click puts Value8 N.V on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
